The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Access to Data and Biospecimens, 2014LRRK2 in Urine as a Biomarker for PD
Objective/Rationale:
A mutation in the LRRK2 gene is the most common known genetic cause of Parkinson’s disease (PD). Not everyone who has the LRRK2 mutation will develop PD, but there are... -
Therapeutic Pipeline Program, 2015Improving Access to Depression Care in Parkinson’s Disease: A Telehealth Approach
Study Rationale:
There is a critical need for treatments that address depression and barriers to care among the approximately 5 million people living with Parkinson’s disease (PD)... -
Rapid Response Innovation Awards, 2014Role of Parkin and Its Opponent in Parkinson’s Disease Onset
Study Rationale:
Parkin is an enzyme that adds molecules to proteins, including one called mitofusin, which bridges mitochondria (cell’s powerhouse) to the endoplasmic reticulum (structure... -
Research Grant, 2014Validation of the Movement Disorders Society’s Clinical Criteria of Parkinson’s Disease
Study Rationale:
Diagnosis of Parkinson’s disease (PD) and other causes of parkinsonism is not always an easy task for physicians. An accurate diagnosis, however, is an essential aspect of care for... -
Biomarker Development, 2015Comparison of Pre- and Post-mortem Cerebrospinal Fluid Levels of Proteins and Lipids
Study Rationale:
Alpha-synuclein aggregation in the brain is the main pathology of Parkinson’s disease (PD). Cerebrospinal fluid (CSF) levels of alpha-synuclein are lower in PD. It... -
Dyskinesia Challenge, 2015Biomarkers and Sensors for Levodopa-induced Dyskinesia
Study Rationale:
Levodopa is the gold-standard drug for treatment of Parkinson’s disease (PD), but chronic use is associated with serious motor complications called levodopa-induced...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.